Evidence map›Paper›PMID 42880934›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2026

[IgG4-related disease presenting with involvement of the eyes, pituitary gland and nervous system: A case report].

Cheng Hao, Zewang Li, Longyan Qin, Yi Yin

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cheng HaoDepartment of Radiology, Affiliated Hospital of Guizhou Medical University, Guiyang 550000, China.
Zewang LiDepartment of Radiology, Affiliated Hospital of Guizhou Medical University, Guiyang 550000, China.
Longyan QinDepartment of Rheumatology and Immunology, Affiliated Hospital of Guizhou Medical University, Guiyang 550000, China.
Yi YinDepartment of Radiology, Affiliated Hospital of Guizhou Medical University, Guiyang 550000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To report a case of IgG4-related disease (IgG4-RD) involving the eyes, pituitary gland, dura mater and temporal region simultaneously. The patient was a 55-year-old middle-aged male with a protracted course of more than 13 years. The main clinical manifestations included swelling of the left eye accompanied by exophthalmos, which gradually worsened, and progressive visual deterioration. Imaging examinations revealed multiple pseudotumorous masses in the bilateral extraconal spaces (superior to the bilateral superior rectus muscles and inferior to the bilateral inferior rectus muscles) and the left optic nerve sheath area, pseudotumorous thickening of the bilateral temporal dura mater, sellar nodules, as well as pseudotumorous thickening of the muscular tissues in the left temporal and maxillofacial regions. Laboratory tests showed elevated serum IgG4 levels. Pathohistological biopsy of the ocular tissue demonstrated lymphoid hyperplasia accompanied by whorled or storiform proliferative fibrous tissue, formation of lymphoid follicles, and plasma cell infiltration. Immunohistochemical staining was positive for IgG4, with the ratio of IgG4-positive plasma cells to total IgG-positive plasma cells exceeding 70%. After treatment with hormones combined with immunosuppressants, the lesions in these areas shrank and some disappeared. Therefore, the comprehensive diagnosis was IgG4-RD.

Indexed as

Eye DiseasesImmunoglobulin GImmunoglobulin G4-Related DiseasePituitary DiseasesHumansMaleMiddle AgedImmunoglobulin GCentral nervous systemEyesIgG4-related diseasespituitary gland

Identifiers

PMID42880934
PMCPMC13672241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.